Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: MERCK SHARP & DOHME LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2021-06-07 to 2023-01-15
Current total value of award: $2204799848
Description: :COVID-19: MODIFICATION TO EXERCISE OPTIONS 1001 AND 2001 FOR ORAL ANTIVIRAL  MK-4482 (MOLNUPIRAVIR) TREATMENT DOSES.